semaglutide pancreatitis legal team in louisiana Ozempic / Wegovy / Lawsuit World Diabetes Day takes place

New Jersey, 2017: Forty-one patients suffered septic arthritis from joint injections for osteoarthritic knee pain

News provided by Novo Nordisk Jul 01, 2026, 07:00 ET Starting today, eligible Medicare patients living with obesity can access Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers adults living with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major cardiovascular events including death, heart attack, or stroke in adults with obesity and heart disease a claim only Wegovy can make Since launching in January 2026, Wegovy pill has reached 3 million prescriptions * Medicare GLP-1 Bridge participation now expands patient access to authentic, FDA-approved Wegovy , including the Wegovy pill PLAINSBORO, N.J., July 1, 2026 /PRNewswire/ -- Starting today FDA-approved Wegovy (semaglutide) is available through the Medicare GLP-1 Bridge, a new access pathway for millions of older adults living with obesity

Countries in Asia-Pacific and Latin America are witnessing increasing adoption of GLP-1 drugs, supported by rising health awareness and government initiatives for chronic disease management

57.7%), compared to 36.4% in the non-counterfeit group

The bookings kept coming